Hudson, Wis.–based Phillips-Medisize, a Molex company, said in a news release that the Aria platform introduces a small, simple smart injection device with a reusable electronic drive unit and single-use, disposable cassettes.
The company designed the Aria autoinjector to mirror the compact size and look and feel of existing disposable autoinjectors with straightforward operation powered by sound and light signals indicating dose progress and completion — and simple sleeve-triggered activation needle safety features.
A recent user study demonstrated that 100% of experienced and novice users completed self-injection without training, while no users lifted the device too early during the injection, the company said.
Phillips-Medisize designed the reusable drive and disposable cassette to help meet sustainability mandates with a greener drug delivery device, reducing the storage required and the waste generated by disposable autoinjectors.
The Aria platform can accommodate both 1 ml and 2.25 ml syringes in a common cassette. It can deliver a wide range of drug viscosities, Phillips-Medisize said, while its drive unit has a three-year lifespan. The device can support drug portfolios of innovator companies and for biosimilars and generics, the company said.
Additionally, Aria includes built-in Bluetooth and optional RFID connectivity to ensure seamless data sharing of time-stamped dosing logs with smartphones, tablets and mobile healthcare apps to promote patient engagement and improve medication adherence.
“With the Aria smart autoinjector, we are disrupting this sector with a game-changing platform that brings the right functionality to market in the right form factor at the right time,” Phillips-Medisize VP of innovation Kevin Deane said in the release. “Our goal from the outset has been to develop an injector that patients love, combining the simplicity of current disposable devices with the superior performance, sustainability and connectivity possible through an electronic, reusable device.”
